{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:00:35Z","timestamp":1794294035054,"version":"4.9.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Metab Health Dis"],"DOI":"10.1038\/s44324-026-00103-7","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:26:46Z","timestamp":1784014006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Paraoxonases as metabolic and signaling modulators: prospects for therapeutic and preventive implications"],"prefix":"10.1038","volume":"4","author":[{"given":"Sepand","family":"Tehrani Fateh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahand","family":"Tehrani Fateh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Ali","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"103_CR1","doi-asserted-by":"publisher","first-page":"122","DOI":"10.11613\/BM.2011.020","volume":"21","author":"M Grdic Rajkovic","year":"2011","unstructured":"Grdic Rajkovic, M., Rumora, L. & Barisic, K. The paraoxonase 1, 2 and 3 in humans. Biochem. Med. 21, 122\u2013130 (2011).","journal-title":"Biochem. Med."},{"key":"103_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0021-9258(18)43068-2","volume":"164","author":"A Mazur","year":"1946","unstructured":"Mazur, A. An enzyme in animal tissues capable of hydrolyzing the phosphorus-fluorine bond of alkyl fluorophosphates. J. Biol. Chem. 164, 271\u2013289 (1946).","journal-title":"J. Biol. Chem."},{"key":"103_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/antiox11030590","volume":"11","author":"CJ Mohammed","year":"2022","unstructured":"Mohammed, C. J. et al. A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease. Antioxidants 11, 590 (2022).","journal-title":"Antioxidants"},{"key":"103_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1194\/jlr.M400511-JLR200","volume":"46","author":"DI Draganov","year":"2005","unstructured":"Draganov, D. I. et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. lipid Res. 46, 1239\u20131247 (2005).","journal-title":"J. lipid Res."},{"key":"103_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","volume":"21","author":"ST Reddy","year":"2001","unstructured":"Reddy, S. T. et al. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler. Thromb. Vasc. Biol. 21, 542\u2013547 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR6","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1074\/jbc.M107440200","volume":"277","author":"S Deakin","year":"2002","unstructured":"Deakin, S. et al. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J. Biol. Chem. 277, 4301\u20134308 (2002).","journal-title":"J. Biol. Chem."},{"key":"103_CR7","doi-asserted-by":"publisher","first-page":"44444","DOI":"10.1074\/jbc.M105660200","volume":"276","author":"CJ Ng","year":"2001","unstructured":"Ng, C. J. et al. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276, 44444\u201344449 (2001).","journal-title":"J. Biol. Chem."},{"key":"103_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2009.09.025","volume":"410","author":"B Goswami","year":"2009","unstructured":"Goswami, B. et al. Paraoxonase: a multifaceted biomolecule. Clin. Chim. Acta 410, 1\u201312 (2009).","journal-title":"Clin. Chim. Acta"},{"key":"103_CR9","doi-asserted-by":"publisher","first-page":"613780","DOI":"10.3389\/fphar.2020.613780","volume":"11","author":"AV Poznyak","year":"2021","unstructured":"Poznyak, A. V. et al. Overview of OxLDL and its impact on cardiovascular health: focus on atherosclerosis. Front. Pharmacol. 11, 613780 (2021).","journal-title":"Front. Pharmacol."},{"key":"103_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","volume":"63","author":"W Liu","year":"2014","unstructured":"Liu, W. et al. OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation. Inflamm. Res. 63, 33\u201343 (2014).","journal-title":"Inflamm. Res."},{"key":"103_CR11","doi-asserted-by":"publisher","first-page":"7657","DOI":"10.1074\/jbc.M512595200","volume":"281","author":"M Rosenblat","year":"2006","unstructured":"Rosenblat, M. et al. The catalytic histidine dyad of high-density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low-density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J. Biol. Chem. 281, 7657\u20137665 (2006).","journal-title":"J. Biol. Chem."},{"key":"103_CR12","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.bbrc.2004.04.056","volume":"318","author":"B Mackness","year":"2004","unstructured":"Mackness, B. et al. Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem. Biophys. Res. Commun. 318, 680\u2013683 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"103_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/B978-0-12-800094-6.00007-8","volume":"63","author":"J Camps","year":"2014","unstructured":"Camps, J. et al. Paraoxonases and chemokine (C\u2013C Motif) ligand-2 in noncommunicable diseases. Adv. Clin. Chem. 63, 247\u2013308 (2014).","journal-title":"Adv. Clin. Chem."},{"key":"103_CR14","doi-asserted-by":"publisher","first-page":"110553","DOI":"10.1016\/j.cbi.2023.110553","volume":"380","author":"J Camps","year":"2023","unstructured":"Camps, J. et al. Paraoxonase-1: How a xenobiotic detoxifying enzyme has become an actor in the pathophysiology of infectious diseases and cancer. Chem.-Biol. Interact. 380, 110553 (2023).","journal-title":"Chem.-Biol. Interact."},{"key":"103_CR15","doi-asserted-by":"publisher","first-page":"24398","DOI":"10.1074\/jbc.M110.118604","volume":"285","author":"S Altenh\u00f6fer","year":"2010","unstructured":"Altenh\u00f6fer, S. et al. One enzyme, two functions: PON2 prevents mitochondrial superoxide formation and apoptosis independent from its lactonase activity. J. Biol. Chem. 285, 24398\u201324403 (2010).","journal-title":"J. Biol. Chem."},{"key":"103_CR16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1161\/CIRCULATIONAHA.106.681700","volume":"115","author":"S Horke","year":"2007","unstructured":"Horke, S. et al. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress\u2013induced caspase activation. Circulation 115, 2055\u20132064 (2007).","journal-title":"Circulation"},{"key":"103_CR17","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/cdd.2012.35","volume":"19","author":"E Schweikert","year":"2012","unstructured":"Schweikert, E. et al. PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death. Cell Death Differ. 19, 1549\u20131560 (2012).","journal-title":"Cell Death Differ."},{"key":"103_CR18","doi-asserted-by":"publisher","first-page":"33435","DOI":"10.1074\/jbc.M004543200","volume":"275","author":"DI Draganov","year":"2000","unstructured":"Draganov, D. I. et al. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J. Biol. Chem. 275, 33435\u201333442 (2000).","journal-title":"J. Biol. Chem."},{"key":"103_CR19","doi-asserted-by":"publisher","first-page":"1065967","DOI":"10.3389\/fcvm.2023.1065967","volume":"10","author":"PN Durrington","year":"2023","unstructured":"Durrington, P. N., Bashir, B. & Soran, H. Paraoxonase 1 and atherosclerosis. Front. Cardiovasc. Med. 10, 1065967 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"103_CR20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/ars.2010.3430","volume":"14","author":"A Devarajan","year":"2011","unstructured":"Devarajan, A. et al. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. Antioxid. Redox Signal. 14, 341\u2013351 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"103_CR21","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1210\/jc.2003-030648","volume":"88","author":"M Senti\u0301","year":"2003","unstructured":"Senti\u0301, M. et al. Antioxidant paraoxonase 1 activity in the metabolic syndrome. J. Clin. Endocrinol. Metab. 88, 5422\u20135426 (2003). p.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"103_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25802-1","volume":"12","author":"G-C Shin","year":"2022","unstructured":"Shin, G.-C. et al. Paraoxonase-2 contributes to promoting lipid metabolism and mitochondrial function via autophagy activation. Sci. Rep. 12, 21483 (2022).","journal-title":"Sci. Rep."},{"key":"103_CR23","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1038\/cddis.2010.91","volume":"2","author":"I Witte","year":"2011","unstructured":"Witte, I. et al. Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells. Cell Death Dis. 2, e112 (2011).","journal-title":"Cell Death Dis."},{"key":"103_CR24","doi-asserted-by":"publisher","first-page":"70045","DOI":"10.18632\/oncotarget.12145","volume":"7","author":"J Cai","year":"2016","unstructured":"Cai, J. et al. Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma. Oncotarget 7, 70045 (2016).","journal-title":"Oncotarget"},{"key":"103_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0657-1","volume":"18","author":"D Huang","year":"2018","unstructured":"Huang, D. et al. Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer. Cancer Cell Int. 18, 168 (2018).","journal-title":"Cancer Cell Int."},{"key":"103_CR26","doi-asserted-by":"publisher","first-page":"12780","DOI":"10.1073\/pnas.0805865105","volume":"105","author":"RC Stevens","year":"2008","unstructured":"Stevens, R. C. et al. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc. Natl. Acad. Sci. 105, 12780\u201312784 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"103_CR27","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1021\/acschembio.6b00527","volume":"11","author":"XC Li","year":"2016","unstructured":"Li, X. C. et al. Engineering soluble human paraoxonase 2 for quorum quenching. ACS Chem. Biol. 11, 3122\u20133131 (2016).","journal-title":"ACS Chem. Biol."},{"key":"103_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0090-9556(25)07065-5","volume":"19","author":"KN Gan","year":"1991","unstructured":"Gan, K. N. et al. Purification of human serum paraoxonase\/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab. Dispos. 19, 100\u2013106 (1991).","journal-title":"Drug Metab. Dispos."},{"key":"103_CR29","doi-asserted-by":"publisher","first-page":"10133","DOI":"10.1021\/bi00106a009","volume":"30","author":"CE Furlong","year":"1991","unstructured":"Furlong, C. E. et al. Purification of rabbit and human serum paraoxonase. Biochemistry 30, 10133\u201310140 (1991).","journal-title":"Biochemistry"},{"key":"103_CR30","doi-asserted-by":"publisher","first-page":"26036","DOI":"10.1007\/s11356-020-08937-4","volume":"27","author":"AM Badr","year":"2020","unstructured":"Badr, A. M. Organophosphate toxicity: Updates of malathion potential toxic effects in mammals and potential treatments. Environ. Sci. Pollut. Res. 27, 26036\u201326057 (2020).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"103_CR31","doi-asserted-by":"publisher","first-page":"117863021769414","DOI":"10.1177\/1178630217694149","volume":"11","author":"L Razwiedani","year":"2017","unstructured":"Razwiedani, L. & Rautenbach, P. Epidemiology of organophosphate poisoning in the Tshwane District of South Africa. Environ. health insights 11, 1178630217694149 (2017).","journal-title":"Environ. health insights"},{"key":"103_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/0960327115584990","volume":"35","author":"N Pakravan","year":"2016","unstructured":"Pakravan, N. et al. Measurement of cholinesterase enzyme activity before and after exposure to organophosphate pesticides in farmers of a suburban region of Mazandaran, a northern province of Iran. Hum. Exp. Toxicol. 35, 297\u2013301 (2016).","journal-title":"Hum. Exp. Toxicol."},{"key":"103_CR33","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1021\/acs.estlett.0c00916","volume":"8","author":"G Zheng","year":"2021","unstructured":"Zheng, G. et al. Organophosphate esters and their metabolites in breast milk from the United States: Breastfeeding is an important exposure pathway for infants. Environ. Sci. Technol. Lett. 8, 224\u2013230 (2021).","journal-title":"Environ. Sci. Technol. Lett."},{"key":"103_CR34","doi-asserted-by":"publisher","first-page":"14852","DOI":"10.1007\/s11356-020-08001-1","volume":"27","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. Occurrence, composition and biological risk of organophosphate esters (OPEs) in water of the Pearl River Estuary, South China. Environ. Sci. Pollut. Res. 27, 14852\u201314862 (2020).","journal-title":"Environ. Sci. Pollut. Res."},{"key":"103_CR35","first-page":"UC18","volume":"10","author":"G Patil","year":"2016","unstructured":"Patil, G., Murthy, N. & Nikhil, M. Contributing factors for morbidity and mortality in patients with organophosphate poisoning on mechanical ventilation: a retrospective study in a teaching hospital. J. Clin. Diagn. Res. 10, UC18 (2016).","journal-title":"J. Clin. Diagn. Res."},{"key":"103_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.neuro.2012.03.011","volume":"33","author":"Y Chen","year":"2012","unstructured":"Chen, Y. Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicology 33, 391\u2013400 (2012).","journal-title":"Neurotoxicology"},{"key":"103_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/occmed\/kqh018","volume":"54","author":"R Kamanyire","year":"2004","unstructured":"Kamanyire, R. & Karalliedde, L. Organophosphate toxicity and occupational exposure. Occup. Med. 54, 69\u201375 (2004).","journal-title":"Occup. Med."},{"key":"103_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11684-018-0626-z","volume":"13","author":"R Hou","year":"2019","unstructured":"Hou, R. et al. Total pancreatic necrosis after organophosphate intoxication. Front. Med. 13, 285\u2013288 (2019).","journal-title":"Front. Med."},{"key":"103_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/15563659609013800","volume":"34","author":"C-T Hsiao","year":"1996","unstructured":"Hsiao, C.-T. et al. Acute pancreatitis following organophosphate intoxication. J. Toxicol. Clin. Toxicol. 34, 343\u2013347 (1996).","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"103_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/hrt.77.5.461","volume":"77","author":"A Saadeh","year":"1997","unstructured":"Saadeh, A., Farsakh, N. & Al-Ali, M. Cardiac manifestations of acute carbamate and organophosphate poisoning. Heart 77, 461\u2013464 (1997).","journal-title":"Heart"},{"key":"103_CR41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/15563650902724813","volume":"47","author":"S Anand","year":"2009","unstructured":"Anand, S. et al. Cardiac abnormalities in acute organophosphate poisoning. Clin. Toxicol. 47, 230\u2013235 (2009).","journal-title":"Clin. Toxicol."},{"key":"103_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-021-01981-5","volume":"21","author":"W Hung","year":"2021","unstructured":"Hung, W., Tsai, T.-H. & Chen, J.-H. A case report of delayed lower intestinal bleeding after organophosphate poisoning. BMC Gastroenterol. 21, 1\u20134 (2021).","journal-title":"BMC Gastroenterol."},{"key":"103_CR43","doi-asserted-by":"publisher","first-page":"110548","DOI":"10.1016\/j.ecoenv.2020.110548","volume":"196","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Positive correlation between human exposure to organophosphate esters and gastrointestinal cancer in patients from Wuhan, China. Ecotoxicol. Environ. Saf. 196, 110548 (2020).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"103_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-7-140","volume":"7","author":"FR Chowdhury","year":"2014","unstructured":"Chowdhury, F. R. et al. Organophosphate poisoning presenting with muscular weakness and abdominal pain-a case report. BMC Res. Notes 7, 1\u20133 (2014).","journal-title":"BMC Res. Notes"},{"key":"103_CR45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/07853899909115981","volume":"31","author":"RA Hegele","year":"1999","unstructured":"Hegele, R. A. Paraoxonase genes and disease. Ann. Med. 31, 217\u2013224 (1999).","journal-title":"Ann. Med."},{"key":"103_CR46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/15287399309531798","volume":"40","author":"WF Li","year":"1993","unstructured":"Li, W. F., Costa, L. G. & Furlong, C. E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health, Part A Curr. Issues 40, 337\u2013346 (1993).","journal-title":"J. Toxicol. Environ. Health, Part A Curr. Issues"},{"key":"103_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0378-4274(95)80006-Y","volume":"76","author":"WF Li","year":"1995","unstructured":"Li, W. F., Furlong, C. E. & Costa, L. G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76, 219\u2013226 (1995).","journal-title":"Toxicol. Lett."},{"key":"103_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tox.2006.08.037","volume":"233","author":"D Rochu","year":"2007","unstructured":"Rochu, D., Chabri\u00e8re, E. & Masson, P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 233, 47\u201359 (2007).","journal-title":"Toxicology"},{"key":"103_CR49","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/01.ATV.21.4.473","volume":"21","author":"P Durrington","year":"2001","unstructured":"Durrington, P., Mackness, B. & Mackness, M. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21, 473\u2013480 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR50","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/1570161115666171129212359","volume":"17","author":"S Lioudaki","year":"2019","unstructured":"Lioudaki, S. et al. Paraoxonase-1: Characteristics and role in atherosclerosis and carotid artery disease. Curr. Vasc. Pharmacol. 17, 141\u2013146 (2019).","journal-title":"Curr. Vasc. Pharmacol."},{"key":"103_CR51","doi-asserted-by":"crossref","unstructured":"Aviram, M. et al. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Atheroscler. Diet Drugs 2005: 263\u2013300.","DOI":"10.1007\/3-540-27661-0_9"},{"key":"103_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/biof.1549","volume":"46","author":"J Kotur-Stevuljevi\u0107","year":"2020","unstructured":"Kotur-Stevuljevi\u0107, J. et al. Paraoxonase 1 and atherosclerosis-related diseases. Biofactors 46, 193\u2013205 (2020).","journal-title":"Biofactors"},{"key":"103_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2011.06.054","volume":"219","author":"M Rosenblat","year":"2011","unstructured":"Rosenblat, M. et al. Paraoxonase 1 (PON1) inhibits monocyte-to-macrophage differentiation. Atherosclerosis 219, 49\u201356 (2011).","journal-title":"Atherosclerosis"},{"key":"103_CR54","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/biof.188","volume":"37","author":"M Rosenblat","year":"2011","unstructured":"Rosenblat, M., Volkova, N. & Aviram, M. Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity. Biofactors 37, 462\u2013467 (2011).","journal-title":"Biofactors"},{"key":"103_CR55","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/1873-3468.12198","volume":"590","author":"S Ikhlef","year":"2016","unstructured":"Ikhlef, S. et al. Paraoxonase 1-treated ox LDL promotes cholesterol efflux from macrophages by stimulating the PPAR \u03b3\u2013LXR \u03b1\u2013ABCA 1 pathway. FEBS Lett. 590, 1614\u20131629 (2016).","journal-title":"FEBS Lett."},{"key":"103_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-micro-032020-093845","volume":"74","author":"S Azimi","year":"2020","unstructured":"Azimi, S. et al. Bacterial quorum sensing during infection. Annu. Rev. Microbiol. 74, 201\u2013219 (2020).","journal-title":"Annu. Rev. Microbiol."},{"key":"103_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1369-5274(03)00008-0","volume":"6","author":"RS Smith","year":"2003","unstructured":"Smith, R. S. & Iglewski, B. H. P. aeruginosa quorum-sensing systems and virulence. Curr. Opin. Microbiol. 6, 56\u201360 (2003).","journal-title":"Curr. Opin. Microbiol."},{"key":"103_CR58","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4161\/viru.25338","volume":"4","author":"A Suppiger","year":"2013","unstructured":"Suppiger, A. et al. Two quorum-sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex. Virulence 4, 400\u2013409 (2013).","journal-title":"Virulence"},{"key":"103_CR59","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.1128\/IAI.67.10.5192-5199.1999","volume":"67","author":"S Swift","year":"1999","unstructured":"Swift, S. et al. Quorum sensing-dependent regulation and blockade of exoprotease production in Aeromonas hydrophila. Infect. Immun. 67, 5192\u20135199 (1999).","journal-title":"Infect. Immun."},{"key":"103_CR60","doi-asserted-by":"publisher","first-page":"104266","DOI":"10.1016\/j.micpath.2020.104266","volume":"147","author":"W Liu","year":"2020","unstructured":"Liu, W. et al. Tea polyphenols inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances resistance to Klebsiella pneumoniae infection in Caenorhabditis elegans model. Microb. Pathog. 147, 104266 (2020).","journal-title":"Microb. Pathog."},{"key":"103_CR61","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/35081101","volume":"411","author":"Y-H Dong","year":"2001","unstructured":"Dong, Y.-H. et al. Quenching quorum-sensing-dependent bacterial infection by an N-acyl homoserine lactonase. Nature 411, 813\u2013817 (2001).","journal-title":"Nature"},{"key":"103_CR62","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3389\/fmicb.2015.01173","volume":"6","author":"K-G Chan","year":"2015","unstructured":"Chan, K.-G., Liu, Y.-C. & Chang, C.-Y. Inhibiting N-acyl-homoserine lactone synthesis and quenching Pseudomonas quinolone quorum sensing to attenuate virulence. Front. Microbiol. 6, 1173 (2015).","journal-title":"Front. Microbiol."},{"key":"103_CR63","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1128\/AEM.06139-11","volume":"78","author":"Y Cao","year":"2012","unstructured":"Cao, Y. et al. Orally administered thermostable N-acyl homoserine lactonase from Bacillus sp. strain AI96 attenuates Aeromonas hydrophila infection in zebrafish. Appl. Environ. Microbiol. 78, 1899\u20131908 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"103_CR64","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1073\/pnas.2536901100","volume":"101","author":"A Aharoni","year":"2004","unstructured":"Aharoni, A. et al. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc. Natl. Acad. Sci. 101, 482\u2013487 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"103_CR65","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/1440-1681.12275","volume":"41","author":"ZK Han","year":"2014","unstructured":"Han, Z. K. et al. Preparation of paraoxonase-1 liposomes and studies on their in vivo pharmacokinetics in rats. Clin. Exp. Pharmacol. Physiol. 41, 825\u2013829 (2014).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"103_CR66","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1166\/jnn.2010.2828","volume":"10","author":"F Kockar","year":"2010","unstructured":"Kockar, F. et al. Paraoxonase 1-bound magnetic nanoparticles: preparation and characterizations. J. Nanosci. Nanotechnol. 10, 7554\u20137559 (2010).","journal-title":"J. Nanosci. Nanotechnol."},{"key":"103_CR67","doi-asserted-by":"publisher","first-page":"110209","DOI":"10.1016\/j.enzmictec.2023.110209","volume":"165","author":"P Dobariya","year":"2023","unstructured":"Dobariya, P. et al. Fused human paraoxonase 1 as a prophylactic agent against organophosphate poisoning. Enzym. Microb. Technol. 165, 110209 (2023).","journal-title":"Enzym. Microb. Technol."},{"key":"103_CR68","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1021\/mp800113g","volume":"5","author":"RJ Boado","year":"2008","unstructured":"Boado, R. J. et al. IgG-paraoxonase-1 fusion protein for targeted drug delivery across the human blood\u2212 brain barrier. Mol. Pharm. 5, 1037\u20131043 (2008).","journal-title":"Mol. Pharm."},{"key":"103_CR69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"103_CR70","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/ptr.6655","volume":"34","author":"M Tabatabaie","year":"2020","unstructured":"Tabatabaie, M. et al. The effect of resveratrol supplementation on serum levels of asymmetric de-methyl-arginine and paraoxonase 1 activity in patients with type 2 diabetes: a randomized, double-blind controlled trial. Phytother. Res. 34, 2023\u20132031 (2020).","journal-title":"Phytother. Res."},{"key":"103_CR71","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cbic.201300754","volume":"15","author":"E Calleri","year":"2014","unstructured":"Calleri, E. et al. Resveratrol and its metabolites bind to PPARs. ChemBioChem 15, 1154\u20131160 (2014).","journal-title":"ChemBioChem"},{"key":"103_CR72","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/07391102.2020.1820380","volume":"40","author":"KB Lokhande","year":"2022","unstructured":"Lokhande, K. B. et al. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-\u03b3: docking, molecular dynamics and MM\/GBSA approach to reveal potent PPAR-\u03b3 agonist against cancer. J. Biomol. Struct. Dyn. 40, 971\u2013981 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"103_CR73","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1161\/01.ATV.0000146530.24736.ce","volume":"24","author":"CD Goue\u0301dard","year":"2004","unstructured":"Goue\u0301dard, C. D., Barouki, R. & Morel, Y. Induction of the paraoxonase-1 gene expression by resveratrol. Arterioscler. Thromb, Vasc. Biol. 24, 2378\u20132383 (2004). p.","journal-title":"Arterioscler. Thromb, Vasc. Biol."},{"key":"103_CR74","doi-asserted-by":"publisher","first-page":"113234","DOI":"10.1016\/j.expneurol.2020.113234","volume":"327","author":"JK Blackburn","year":"2020","unstructured":"Blackburn, J. K. et al. Pioglitazone activates paraoxonase-2 in the brain: a novel neuroprotective mechanism. Exp. Neurol. 327, 113234 (2020).","journal-title":"Exp. Neurol."},{"key":"103_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-019-0431-0","volume":"11","author":"DF Roxo","year":"2019","unstructured":"Roxo, D. F. et al. Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats. Diabetol. Metab. Syndr. 11, 1\u20138 (2019).","journal-title":"Diabetol. Metab. Syndr."},{"key":"103_CR76","doi-asserted-by":"publisher","first-page":"e0218934","DOI":"10.1371\/journal.pone.0218934","volume":"14","author":"H Halim","year":"2019","unstructured":"Halim, H. et al. Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel. PloS one 14, e0218934 (2019).","journal-title":"PloS one"},{"key":"103_CR77","doi-asserted-by":"publisher","first-page":"14666","DOI":"10.18632\/oncotarget.14716","volume":"8","author":"J-H Tseng","year":"2017","unstructured":"Tseng, J.-H. et al. Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression. Oncotarget 8, 14666 (2017).","journal-title":"Oncotarget"},{"key":"103_CR78","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1124\/mol.63.4.945","volume":"63","author":"C Gou\u00e9dard","year":"2003","unstructured":"Gou\u00e9dard, C. et al. Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins. Mol. Pharmacol. 63, 945\u2013956 (2003).","journal-title":"Mol. Pharmacol."},{"key":"103_CR79","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.metabol.2016.01.002","volume":"65","author":"A Sahebkar","year":"2016","unstructured":"Sahebkar, A. et al. Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status. Metabolism 65, 609\u2013622 (2016).","journal-title":"Metabolism"},{"key":"103_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00005344-200401000-00018","volume":"43","author":"J Beltowski","year":"2004","unstructured":"Beltowski, J., W\u00f3jcicka, G. & Jamroz, A. Effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors (statins) on tissue paraoxonase 1 and plasma platelet-activating factor acetylhydrolase activities. J. Cardiovasc. Pharmacol. 43, 121\u2013127 (2004).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"103_CR81","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1161\/01.ATV.0000096207.01487.36","volume":"23","author":"S Deakin","year":"2003","unstructured":"Deakin, S. et al. Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element\u2013binding protein-2. Arterioscler. Thromb. Vasc. Biol. 23, 2083\u20132089 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","volume":"60","author":"G Ferretti","year":"2015","unstructured":"Ferretti, G., Bacchetti, T. & Sahebkar, A. Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog. Lipid Res. 60, 50\u201373 (2015).","journal-title":"Prog. Lipid Res."},{"key":"103_CR83","doi-asserted-by":"crossref","unstructured":"W\u00f3jcicka, G. et al. The effect of exenatide (GLP-1a) and sitagliptin (DPP-4i) on paraoxonase 1 (PON1) activity and expression in normal and fructose-fed rats. Eur. J. Pharmacol. 178197 (2025).","DOI":"10.1016\/j.ejphar.2025.178197"},{"key":"103_CR84","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/ddr.21667","volume":"81","author":"Y Demir","year":"2020","unstructured":"Demir, Y. Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases. Drug Dev. Res. 81, 628\u2013636 (2020).","journal-title":"Drug Dev. Res."},{"key":"103_CR85","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/01480545.2019.1620266","volume":"44","author":"\u015e Beydemir","year":"2021","unstructured":"Beydemir, \u015e., T\u00fcrke\u015f, C. & Yal\u00e7\u0131n, A. Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies. Drug Chem. Toxicol. 44, 508\u2013517 (2021).","journal-title":"Drug Chem. Toxicol."},{"key":"103_CR86","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pharep.2013.08.007","volume":"66","author":"C T\u00fcrke\u015f","year":"2014","unstructured":"T\u00fcrke\u015f, C., S\u00f6y\u00fct, H. & Beydemir, \u015e. Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress. Pharmacol. Rep. 66, 74\u201380 (2014).","journal-title":"Pharmacol. Rep."},{"key":"103_CR87","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.bmc.2016.02.012","volume":"24","author":"MO Karata\u015f","year":"2016","unstructured":"Karata\u015f, M. O. et al. Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies. Bioorg. Med. Chem. 24, 1392\u20131401 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"103_CR88","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/jphp.13141","volume":"71","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f, C. A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors. J. Pharm. Pharmacol. 71, 1553\u20131564 (2019).","journal-title":"J. Pharm. Pharmacol."},{"key":"103_CR89","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/molecules25010211","volume":"25","author":"A Bosak","year":"2020","unstructured":"Bosak, A. et al. Interactions of paraoxonase-1 with pharmacologically relevant carbamates. Molecules 25, 211 (2020).","journal-title":"Molecules"},{"key":"103_CR90","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1002\/slct.201902424","volume":"4","author":"C T\u00fcrke\u015f","year":"2019","unstructured":"T\u00fcrke\u015f, C., Beydemir, \u015e. & K\u00fcfrevio\u011flu, \u00d6. \u0130. In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor. ChemistrySelect 4, 9731\u20139736 (2019).","journal-title":"ChemistrySelect"},{"key":"103_CR91","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12010-019-03073-3","volume":"190","author":"C T\u00fcrke\u015f","year":"2020","unstructured":"T\u00fcrke\u015f, C. & Beydemir, \u015e. Inhibition of human serum paraoxonase-I with antimycotic drugs: in vitro and in silico studies. Appl. Biochem. Biotechnol. 190, 252\u2013269 (2020).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"103_CR92","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.pharep.2019.02.012","volume":"71","author":"Y Demir","year":"2019","unstructured":"Demir, Y. & K\u00f6ksal, Z. The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1). Pharmacol. Rep. 71, 545\u2013549 (2019).","journal-title":"Pharmacol. Rep."},{"key":"103_CR93","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/13813455.2018.1470646","volume":"125","author":"Z Al\u0131m","year":"2019","unstructured":"Al\u0131m, Z., K\u0131l\u0131\u00e7, D. & Demir, Y. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme: in vitro inhibition and molecular modeling studies. Arch. Physiol. Biochem. 125, 387\u2013395 (2019).","journal-title":"Arch. Physiol. Biochem."},{"key":"103_CR94","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/jphp.13144","volume":"71","author":"Y Demir","year":"2019","unstructured":"Demir, Y. The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis. J. Pharm. Pharmacol. 71, 1576\u20131583 (2019).","journal-title":"J. Pharm. Pharmacol."},{"key":"103_CR95","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3109\/14756366.2014.959511","volume":"30","author":"C T\u00fcrke\u015f","year":"2015","unstructured":"T\u00fcrke\u015f, C., S\u00f6y\u00fct, H. & Beydemir, \u015e. Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. J. Enzym. Inhib. Med. Chem. 30, 622\u2013628 (2015).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"103_CR96","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1080\/14756360802608351","volume":"24","author":"D Ekinci","year":"2009","unstructured":"Ekinci, D. & Beydemir, \u015e. Effect of some analgesics on paraoxonase-1 purified from human serum. J. Enzym. Inhib. Med. Chem. 24, 1034\u20131039 (2009).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"103_CR97","first-page":"108608","volume":"226","author":"Y Demir","year":"2019","unstructured":"Demir, Y., Balc\u0131, N. & G\u00fcrb\u00fcz, M. Differential effects of selective serotonin reuptake inhibitors on paraoxonase-1 enzyme activity: An in vitro study. Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol. 226, 108608 (2019).","journal-title":"Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol."},{"key":"103_CR98","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3109\/14756366.2016.1142982","volume":"31","author":"MO Karata\u015f","year":"2016","unstructured":"Karata\u015f, M. O. et al. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors. J. Enzym. Inhib. Med. Chem. 31, 1386\u20131391 (2016).","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"103_CR99","doi-asserted-by":"publisher","first-page":"e5130","DOI":"10.1002\/aoc.5130","volume":"33","author":"MO Karata\u015f","year":"2019","unstructured":"Karata\u015f, M. O. et al. Inhibition of paraoxonase 1 by coumarin-substituted N-heterocyclic carbene silver (I), ruthenium (II) and palladium (II) complexes. Appl. Organomet. Chem. 33, e5130 (2019).","journal-title":"Appl. Organomet. Chem."},{"key":"103_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejps.2015.11.019","volume":"82","author":"AT Marinho","year":"2016","unstructured":"Marinho, A. T. et al. Nevirapine modulation of paraoxonase-1 in the liver: An in vitro three-model approach. Eur. J. Pharm. Sci. 82, 147\u2013153 (2016).","journal-title":"Eur. J. Pharm. Sci."},{"key":"103_CR101","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/13813455.2017.1411371","volume":"124","author":"A Solmaz Avc\u0131kurt","year":"2018","unstructured":"Solmaz Avc\u0131kurt, A. & Korkut, O. Effect of certain non-steroidal anti-inflammatory drugs on the paraoxonase 2 (PON2) in human monocytic cell line U937. Arch. Physiol. Biochem. 124, 378\u2013382 (2018).","journal-title":"Arch. Physiol. Biochem."},{"key":"103_CR102","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1161\/01.ATV.0000027101.40323.3A","volume":"22","author":"GP Jarvik","year":"2002","unstructured":"Jarvik, G. P. et al. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler. Thromb. Vasc. Biol. 22, 1329\u20131333 (2002).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR103","first-page":"159596","volume":"1870","author":"A-G Dedemadi","year":"2025","unstructured":"Dedemadi, A.-G. et al. Dantrolene is an HDL-associated paraoxonase-1 activator with immunosuppressive and atheroprotective properties. Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 1870, 159596 (2025).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"103_CR104","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1111\/bph.16438","volume":"181","author":"GC Shin","year":"2024","unstructured":"Shin, G. C. et al. Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis. Br. J. Pharmacol. 181, 3717\u20133742 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"103_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00896-z","volume":"20","author":"H An","year":"2025","unstructured":"An, H. et al. Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson\u2019s disease. Mol. Neurodegener. 20, 110 (2025).","journal-title":"Mol. Neurodegener."},{"key":"103_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/VHRM.S165173","volume":"14","author":"N Shunmoogam","year":"2018","unstructured":"Shunmoogam, N., Naidoo, P. & Chilton, R. Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance. Vasc. health risk Manag. 14, 137 (2018).","journal-title":"Vasc. health risk Manag."},{"key":"103_CR107","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/FPC.0b013e3280925716","volume":"17","author":"S Deakin","year":"2007","unstructured":"Deakin, S., Guernier, S. & James, R. W. Pharmacogenetic interaction between paraoxonase-1 gene promoter polymorphism C-107T and statin. Pharmacogenet. Genom. 17, 451\u2013457 (2007).","journal-title":"Pharmacogenet. Genom."},{"key":"103_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2019.07.010","volume":"73","author":"A Mahrooz","year":"2019","unstructured":"Mahrooz, A. et al. The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation. Clin. Biochem. 73, 1\u201310 (2019).","journal-title":"Clin. Biochem."},{"key":"103_CR109","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/ng1196-334","volume":"14","author":"HG Davies","year":"1996","unstructured":"Davies, H. G. et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat. Genet. 14, 334\u2013336 (1996).","journal-title":"Nat. Genet."},{"key":"103_CR110","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/01.ATV.0000051702.38086.C1","volume":"23","author":"X Wang","year":"2003","unstructured":"Wang, X. et al. Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arterioscler. Thromb. Vasc. Biol. 23, 328\u2013334 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR111","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.4238\/2013.October.30.2","volume":"12","author":"L Han","year":"2013","unstructured":"Han, L. et al. Association of paraoxonase polymorphisms with carotid artery atherosclerosis in essential hypertension patients. Genet Mol. Res 12, 5174\u20135185 (2013).","journal-title":"Genet Mol. Res"},{"key":"103_CR112","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.clinbiochem.2004.10.005","volume":"38","author":"M Roest","year":"2005","unstructured":"Roest, M. et al. Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia. Clin. Biochem. 38, 123\u2013127 (2005).","journal-title":"Clin. Biochem."},{"key":"103_CR113","doi-asserted-by":"publisher","first-page":"116646","DOI":"10.1016\/j.lfs.2019.116646","volume":"232","author":"Q Zeng","year":"2019","unstructured":"Zeng, Q. & Zeng, J. A meta-analysis on relationship between paraoxonase 1 polymorphisms and atherosclerotic cardiovascular diseases. Life Sci. 232, 116646 (2019).","journal-title":"Life Sci."},{"key":"103_CR114","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0021-9150(99)00324-X","volume":"149","author":"FR Leus","year":"2000","unstructured":"Leus, F. R. et al. Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 149, 371\u2013377 (2000).","journal-title":"Atherosclerosis"},{"key":"103_CR115","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0021-9150(99)00340-8","volume":"149","author":"Y Imai","year":"2000","unstructured":"Imai, Y. et al. Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149, 435\u2013442 (2000).","journal-title":"Atherosclerosis"},{"key":"103_CR116","doi-asserted-by":"crossref","unstructured":"Banerjee, I. Relationship between Paraoxonase 1 (PON1) Gene Polymorphisms and Susceptibility of Stroke: a Meta-Analysis. 449\u2013458 (Springer 2010).","DOI":"10.1007\/s10654-010-9470-4"},{"key":"103_CR117","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1161\/01.ATV.17.12.3565","volume":"17","author":"T Zama","year":"1997","unstructured":"Zama, T. et al. A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese. Arterioscler. Thromb. Vasc. Biol. 17, 3565\u20133569 (1997).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR118","first-page":"464","volume":"13","author":"M Roest","year":"2006","unstructured":"Roest, M. et al. Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia. Eur. J. Prevent. Cardiol. 13, 464\u2013466 (2006).","journal-title":"Eur. J. Prevent. Cardiol."},{"key":"103_CR119","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1399-0004.2007.00753.x","volume":"71","author":"M Saeed","year":"2007","unstructured":"Saeed, M. et al. Interactions and associations of paraoxonase gene cluster polymorphisms with myocardial infarction in a Pakistani population. Clin. Genet. 71, 238\u2013244 (2007).","journal-title":"Clin. Genet."},{"key":"103_CR120","doi-asserted-by":"publisher","first-page":"1449482","DOI":"10.3389\/fdmed.2024.1449482","volume":"5","author":"R Masumoto","year":"2024","unstructured":"Masumoto, R. et al. Single-nucleotide polymorphism rs854560 in paraoxonase-1 regulates the cytodifferentiation of human periodontal ligament cells. Front. Dent. Med. 5, 1449482 (2024).","journal-title":"Front. Dent. Med."},{"key":"103_CR121","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1093\/rheumatology\/keab795","volume":"61","author":"SS Bae","year":"2022","unstructured":"Bae, S. S. et al. Abnormal paraoxonase-1 (PON1) enzyme activity in idiopathic inflammatory myopathies. Rheumatology 61, 2512\u20132523 (2022).","journal-title":"Rheumatology"},{"key":"103_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34396-1","volume":"13","author":"JF Menezes","year":"2023","unstructured":"Menezes, J. F. et al. Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease. Sci. Rep. 13, 7215 (2023).","journal-title":"Sci. Rep."},{"key":"103_CR123","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1212\/01.wnl.0000219565.32247.11","volume":"67","author":"A Slowik","year":"2006","unstructured":"Slowik, A. et al. Paraoxonase gene polymorphisms and sporadic ALS. Neurology 67, 766\u2013770 (2006).","journal-title":"Neurology"},{"key":"103_CR124","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/0891988717731825","volume":"30","author":"Y Nie","year":"2017","unstructured":"Nie, Y. et al. A meta-analysis on the relationship of the PON genes and Alzheimer's disease. J. Geriatr. Psychiatry Neurol. 30, 303\u2013310 (2017).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"103_CR125","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0021-9150(00)00440-8","volume":"154","author":"FR Leus","year":"2001","unstructured":"Leus, F. R. et al. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. Atherosclerosis 154, 641\u2013649 (2001).","journal-title":"Atherosclerosis"},{"key":"103_CR126","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000101462","volume":"23","author":"A Slowik","year":"2007","unstructured":"Slowik, A. et al. Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population. Cerebrovasc. Dis. 23, 395\u2013400 (2007).","journal-title":"Cerebrovasc. Dis."},{"key":"103_CR127","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/00207454.2016.1165675","volume":"127","author":"F Rodr\u00edguez-Esparrag\u00f3n","year":"2017","unstructured":"Rodr\u00edguez-Esparrag\u00f3n, F. et al. Paraoxonase 1 and 2 gene variants and the ischemic stroke risk in Gran Canaria population: an association study and meta-analysis. Int. J. Neurosci. 127, 191\u2013198 (2017).","journal-title":"Int. J. Neurosci."},{"key":"103_CR128","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000329571","volume":"31","author":"A Klimkowicz-Mrowiec","year":"2011","unstructured":"Klimkowicz-Mrowiec, A. et al. Paraoxonase gene polymorphism and the risk for Alzheimer\u2019s disease in the polish population. Dement. Geriatr. Cogn. Disord. 31, 417\u2013423 (2011).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"103_CR129","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1194\/jlr.D014134","volume":"52","author":"G Aragon\u00e8s","year":"2011","unstructured":"Aragon\u00e8s, G. et al. Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study [S]. J. lipid Res. 52, 1055\u20131061 (2011).","journal-title":"J. lipid Res."},{"key":"103_CR130","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/biom9120817","volume":"9","author":"K Priyanka","year":"2019","unstructured":"Priyanka, K., Singh, S. & Gill, K. Paraoxonase 3: Structure and its role in pathophysiology of coronary artery disease. Biomolecules 9, 817 (2019).","journal-title":"Biomolecules"},{"key":"103_CR131","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1042\/cs0980355","volume":"98","author":"B Mackness","year":"2000","unstructured":"Mackness, B. et al. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Clin. Sci. 98, 355\u2013363 (2000).","journal-title":"Clin. Sci."},{"key":"103_CR132","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1161\/01.CIR.0000070954.00271.13","volume":"107","author":"B Mackness","year":"2003","unstructured":"Mackness, B. et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 107, 2775\u20132779 (2003).","journal-title":"Circulation"},{"key":"103_CR133","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1161\/01.ATV.0000222924.62641.aa","volume":"26","author":"B Mackness","year":"2006","unstructured":"Mackness, B. et al. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 26, 1545\u20131550 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR134","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/ATVBAHA.106.134189","volume":"27","author":"CJ Ng","year":"2007","unstructured":"Ng, C. J. et al. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E\u2013deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 1368\u20131374 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"103_CR135","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/gt.2010.11","volume":"17","author":"C Zhang","year":"2010","unstructured":"Zhang, C. et al. Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice. Gene Ther. 17, 626\u2013633 (2010).","journal-title":"Gene Ther."},{"key":"103_CR136","doi-asserted-by":"publisher","first-page":"11029","DOI":"10.1073\/pnas.0502677102","volume":"102","author":"G Bradshaw","year":"2005","unstructured":"Bradshaw, G. et al. Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice. Proc. Natl. Acad. Sci. 102, 11029\u201311034 (2005).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"103_CR137","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1291\/hypres.30.85","volume":"30","author":"M Miyoshi","year":"2007","unstructured":"Miyoshi, M. et al. Gene delivery of paraoxonase-1 inhibits neointimal hyperplasia after arterial balloon-injury in rabbits fed a high-fat diet. Hypertens. Res. 30, 85\u201391 (2007).","journal-title":"Hypertens. Res."},{"key":"103_CR138","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S1995-7645(13)60093-0","volume":"6","author":"J Bai","year":"2013","unstructured":"Bai, J. et al. Inhibitory effect of the paraoxonase gene on the formation of rabbit coronary atherosclerosis. Asian Pac. J. Trop. Med. 6, 544\u2013547 (2013).","journal-title":"Asian Pac. J. Trop. Med."},{"key":"103_CR139","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbrc.2010.05.095","volume":"397","author":"AL Fu","year":"2010","unstructured":"Fu, A. L. & Wu, S. P. Single intravenous injection of plasmid DNA encoding human paraoxonase-1 inhibits hyperlipidemia in rats. Biochem. Biophys. Res. Commun. 397, 257\u2013262 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"103_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-32780-w","volume":"8","author":"L Bai","year":"2018","unstructured":"Bai, L. et al. Paraoxonase 1 knockout rats have impaired T cell development at the CD4\/CD8 double-negative to double-positive transition stage. Sci. Rep. 8, 1\u20139 (2018).","journal-title":"Sci. Rep."},{"key":"103_CR141","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00432-015-1941-2","volume":"141","author":"M Kr\u00fcger","year":"2015","unstructured":"Kr\u00fcger, M. et al. Paraoxonase-2 (PON2) protects oral squamous cell cancer cells against irradiation-induced apoptosis. J. Cancer Res. Clin. Oncol. 141, 1757\u20131766 (2015).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"103_CR142","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2017.07.014","volume":"67","author":"A Nagarajan","year":"2017","unstructured":"Nagarajan, A. et al. Paraoxonase 2 facilitates pancreatic cancer growth and metastasis by stimulating GLUT1-mediated glucose transport. Mol. cell 67, 685\u2013701.e6 (2017).","journal-title":"Mol. cell"},{"key":"103_CR143","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s13577-019-00263-3","volume":"32","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis. Hum. Cell 32, 487\u2013494 (2019).","journal-title":"Hum. Cell"},{"key":"103_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0395-2","volume":"9","author":"A Devarajan","year":"2018","unstructured":"Devarajan, A. et al. Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death Dis. 9, 1\u201316 (2018).","journal-title":"Cell Death Dis."},{"key":"103_CR145","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/antiox9121238","volume":"9","author":"R Campagna","year":"2020","unstructured":"Campagna, R. et al. Paraoxonase-2 silencing enhances sensitivity of A375 melanoma cells to treatment with cisplatin. Antioxidants 9, 1238 (2020).","journal-title":"Antioxidants"},{"key":"103_CR146","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/antiox9020175","volume":"9","author":"S Fumarola","year":"2020","unstructured":"Fumarola, S. et al. Bladder cancer chemosensitivity is affected by paraoxonase-2 expression. Antioxidants 9, 175 (2020).","journal-title":"Antioxidants"},{"key":"103_CR147","doi-asserted-by":"publisher","first-page":"e30572","DOI":"10.1002\/jcb.30572","volume":"125","author":"V Schiavoni","year":"2024","unstructured":"Schiavoni, V. et al. Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines. J. Cell. Biochem. 125, e30572 (2024).","journal-title":"J. Cell. Biochem."},{"key":"103_CR148","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/S0090-9556(24)15082-9","volume":"28","author":"S Billecke","year":"2000","unstructured":"Billecke, S. et al. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispo. 28, 1335\u20131342 (2000).","journal-title":"Drug Metab. Dispo."},{"key":"103_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/taap.2001.9169","volume":"173","author":"J Cowan","year":"2001","unstructured":"Cowan, J. et al. Gene therapy to prevent organophosphate intoxication. Toxicol. Appl. Pharmacol. 173, 1\u20136 (2001).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"103_CR150","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.chembiol.2012.01.017","volume":"19","author":"M Goldsmith","year":"2012","unstructured":"Goldsmith, M. et al. Evolved stereoselective hydrolases for broad-spectrum G-type nerve agent detoxification. Chem. Biol. 19, 456\u2013466 (2012).","journal-title":"Chem. Biol."},{"key":"103_CR151","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nsmb767","volume":"11","author":"M Harel","year":"2004","unstructured":"Harel, M. et al. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol. 11, 412\u2013419 (2004).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"103_CR152","doi-asserted-by":"publisher","first-page":"eaay0356","DOI":"10.1126\/scitranslmed.aay0356","volume":"12","author":"V Betapudi","year":"2020","unstructured":"Betapudi, V. et al. Gene therapy delivering a paraoxonase 1 variant offers long-term prophylactic protection against nerve agents in mice. Sci. Transl. Med. 12, eaay0356 (2020).","journal-title":"Sci. Transl. Med."},{"key":"103_CR153","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbrc.2004.12.194","volume":"328","author":"AL Fu","year":"2005","unstructured":"Fu, A. L., Wang, Y. X. & Sun, M. J. Naked DNA prevents soman intoxication. Biochem. Biophys. Res. Commun. 328, 901\u2013905 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"103_CR154","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.toxlet.2010.01.003","volume":"193","author":"W Peng","year":"2010","unstructured":"Peng, W. et al. Comparative evaluation of the protective potentials of human paraoxonase 1 and 3 against CCl4-induced liver injury. Toxicol. Lett. 193, 159\u2013166 (2010).","journal-title":"Toxicol. Lett."},{"key":"103_CR155","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jgm.1128","volume":"10","author":"C Zhang","year":"2008","unstructured":"Zhang, C. et al. Transgene expression of human PON1 Q in mice protected the liver against CCl4-induced injury. J. Gene Med. 10, 94\u2013100 (2008).","journal-title":"J. Gene Med."},{"key":"103_CR156","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/sj.ejcn.1602918","volume":"63","author":"S Tsakiris","year":"2009","unstructured":"Tsakiris, S. et al. Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1\/arylesterase activities in healthy individuals. Eur. J. Clin. Nutr. 63, 215\u2013221 (2009).","journal-title":"Eur. J. Clin. Nutr."},{"key":"103_CR157","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1194\/jlr.M800493-JLR200","volume":"50","author":"R Romani","year":"2009","unstructured":"Romani, R. et al. Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat. J. lipid Res. 50, 2036\u20132045 (2009).","journal-title":"J. lipid Res."},{"key":"103_CR158","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1123\/pes.22.1.93","volume":"22","author":"A Cakmak","year":"2010","unstructured":"Cakmak, A. et al. Paraoxonase activity in athletic adolescents. Pediatr. Exerc. Sci. 22, 93\u2013104 (2010).","journal-title":"Pediatr. Exerc. Sci."},{"key":"103_CR159","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jshs.2015.01.010","volume":"5","author":"GR Nalcakan","year":"2016","unstructured":"Nalcakan, G. R. et al. Effects of aerobic training on serum paraoxonase activity and its relationship with PON1-192 phenotypes in women. J. Sport Health Sci. 5, 462\u2013468 (2016).","journal-title":"J. Sport Health Sci."},{"key":"103_CR160","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1123\/pes.22.1.60","volume":"22","author":"Z Hamurcu","year":"2010","unstructured":"Hamurcu, Z. et al. Effect of wrestling exercise on oxidative DNA damage, nitric oxide level and paraoxonase activity in adolescent boys. Pediatr. Exerc. Sci. 22, 60\u201368 (2010).","journal-title":"Pediatr. Exerc. Sci."},{"key":"103_CR161","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1080\/02701367.2020.1812493","volume":"93","author":"JK Taylor","year":"2022","unstructured":"Taylor, J. K. et al. The Effects of Acute and Chronic Exercise on Paraoxonase-1 (PON1): A Systematic Review With Meta-Analysis. Res. Q. Exerc. Sport 93, 130\u2013143 (2022).","journal-title":"Res. Q. Exerc. Sport"},{"key":"103_CR162","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jnutbio.2005.07.004","volume":"17","author":"E Thom\u00e0s-Moy\u00e0","year":"2006","unstructured":"Thom\u00e0s-Moy\u00e0, E. et al. Effects of caloric restriction and gender on rat serum paraoxonase 1 activity. J. Nutr. Biochem. 17, 197\u2013203 (2006).","journal-title":"J. Nutr. Biochem."},{"key":"103_CR163","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.3390\/cells8121616","volume":"8","author":"C Morresi","year":"2019","unstructured":"Morresi, C. et al. Effect of high glucose-induced oxidative stress on paraoxonase 2 expression and activity in Caco-2 cells. Cells 8, 1616 (2019).","journal-title":"Cells"},{"key":"103_CR164","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/MCA.0b013e3283109206","volume":"19","author":"C Lu","year":"2008","unstructured":"Lu, C. et al. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose. Coron. Artery Dis. 19, 565\u2013573 (2008).","journal-title":"Coron. Artery Dis."},{"key":"103_CR165","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.metabol.2008.07.032","volume":"57","author":"Y Ikeda","year":"2008","unstructured":"Ikeda, Y. et al. High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes. Metabolism 57, 1725\u20131732 (2008).","journal-title":"Metabolism"},{"key":"103_CR166","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2119\/2006-00078.Thomas-Moya","volume":"13","author":"E Thom\u00e0s-Moy\u00e0","year":"2007","unstructured":"Thom\u00e0s-Moy\u00e0, E. et al. Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol. Med. 13, 203\u2013209 (2007).","journal-title":"Mol. Med."},{"key":"103_CR167","doi-asserted-by":"publisher","first-page":"109758","DOI":"10.1016\/j.cbpc.2023.109758","volume":"274","author":"R van den Boom","year":"2023","unstructured":"van den Boom, R. et al. Combined western diet and bisphenol A exposure induces an oxidative stress-based paraoxonase 1 response in larval zebrafish. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 274, 109758 (2023).","journal-title":"Comp. Biochem. Physiol. Part C Toxicol. Pharmacol."},{"key":"103_CR168","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1053\/meta.2002.36305","volume":"51","author":"NM de Roos","year":"2002","unstructured":"de Roos, N. M. et al. Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Metab.-Clin. Exp. 51, 1534\u20131537 (2002).","journal-title":"Metab.-Clin. Exp."},{"key":"103_CR169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-12-183","volume":"12","author":"DS Kim","year":"2013","unstructured":"Kim, D. S. et al. Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects. Lipids Health Dis. 12, 1\u20139 (2013).","journal-title":"Lipids Health Dis."},{"key":"103_CR170","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/anie.201000044","volume":"50","author":"S Quideau","year":"2011","unstructured":"Quideau, S. et al. Plant polyphenols: chemical properties, biological activities, and synthesis. Angew. Chem. Int. Ed. 50, 586\u2013621 (2011).","journal-title":"Angew. Chem. Int. Ed."},{"key":"103_CR171","doi-asserted-by":"publisher","first-page":"215S","DOI":"10.1093\/ajcn\/81.1.215S","volume":"81","author":"A Scalbert","year":"2005","unstructured":"Scalbert, A., Johnson, I. T. & Saltmarsh, M. Polyphenols: antioxidants and beyond. Am. J. Clin. Nutr. 81, 215S\u2013217S (2005).","journal-title":"Am. J. Clin. Nutr."},{"key":"103_CR172","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1080\/10942912.2016.1220393","volume":"20","author":"M Abbas","year":"2017","unstructured":"Abbas, M. et al. Natural polyphenols: an overview. Int. J. Food Prop. 20, 1689\u20131699 (2017).","journal-title":"Int. J. Food Prop."},{"key":"103_CR173","doi-asserted-by":"crossref","unstructured":"Singla, R.K. et al. Natural Polyphenols: Chemical Classification, Definition of Classes, Subcategories, and Structures. 1397\u20131400 (Oxford University Press, 2019).","DOI":"10.5740\/jaoacint.19-0133"},{"key":"103_CR174","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jnutbio.2017.06.002","volume":"48","author":"D Martini","year":"2017","unstructured":"Martini, D. et al. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression. J. Nutr. Biochem. 48, 1\u20138 (2017).","journal-title":"J. Nutr. Biochem."},{"key":"103_CR175","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00394-017-1394-2","volume":"57","author":"D Estrada-Luna","year":"2018","unstructured":"Estrada-Luna, D. et al. Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet. Eur. J. Nutr. 57, 383\u2013389 (2018).","journal-title":"Eur. J. Nutr."},{"key":"103_CR176","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2007.01.007","volume":"195","author":"M Shiner","year":"2007","unstructured":"Shiner, M., Fuhrman, B. & Aviram, M. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR\u03b3 and AP-1 pathway activation. Atherosclerosis 195, 313\u2013321 (2007).","journal-title":"Atherosclerosis"},{"key":"103_CR177","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.1021\/jf801756x","volume":"56","author":"W Rock","year":"2008","unstructured":"Rock, W. et al. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J. Agric. Food Chem. 56, 8704\u20138713 (2008).","journal-title":"J. Agric. Food Chem."},{"key":"103_CR178","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1002\/jsfa.6620","volume":"94","author":"N Jaiswal","year":"2014","unstructured":"Jaiswal, N. & Rizvi, S. I. Onion extract (Allium cepa L.), quercetin and catechin up-regulate paraoxonase 1 activity with concomitant protection against low-density lipoprotein oxidation in male Wistar rats subjected to oxidative stress. J. Sci. Food Agric. 94, 2752\u20132757 (2014).","journal-title":"J. Sci. Food Agric."},{"key":"103_CR179","doi-asserted-by":"publisher","first-page":"e0261504","DOI":"10.1371\/journal.pone.0261504","volume":"17","author":"DE Winnica","year":"2022","unstructured":"Winnica, D. E. et al. Airway epithelial Paraoxonase-2 in obese asthma. PLoS One 17, e0261504 (2022).","journal-title":"PLoS One"},{"key":"103_CR180","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2009.08.051","volume":"208","author":"J Khateeb","year":"2010","unstructured":"Khateeb, J. et al. Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-\u03b3 pathway. Atherosclerosis 208, 119\u2013125 (2010).","journal-title":"Atherosclerosis"},{"key":"103_CR181","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1128\/MCB.24.12.5209-5222.2004","volume":"24","author":"C Gou\u00e9dard","year":"2004","unstructured":"Gou\u00e9dard, C., Barouki, R. & Morel, Y. Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol. 24, 5209\u20135222 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"103_CR182","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/mnfr.201500441","volume":"60","author":"I Yehuda","year":"2016","unstructured":"Yehuda, I. et al. Glabridin, an isoflavan from licorice root, upregulates paraoxonase 2 expression under hyperglycemia and protects it from oxidation. Mol. Nutr. Food Res. 60, 287\u2013299 (2016).","journal-title":"Mol. Nutr. Food Res."},{"key":"103_CR183","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrg3182","volume":"13","author":"I Cho","year":"2012","unstructured":"Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260\u2013270 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"103_CR184","doi-asserted-by":"publisher","first-page":"6ra14","DOI":"10.1126\/scitranslmed.3000322","volume":"1","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh, P. J. et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 1, 6ra14 (2009).","journal-title":"Sci. Transl. Med."},{"key":"103_CR185","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","volume":"149","author":"NG Rossen","year":"2015","unstructured":"Rossen, N. G. et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149, 110\u2013118.e4 (2015).","journal-title":"Gastroenterology"},{"key":"103_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0294-z","volume":"8","author":"A Langdon","year":"2016","unstructured":"Langdon, A., Crook, N. & Dantas, G. The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med. 8, 1\u201316 (2016).","journal-title":"Genome Med."},{"key":"103_CR187","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1053\/j.gastro.2009.01.072","volume":"136","author":"GA Preidis","year":"2009","unstructured":"Preidis, G. A. & Versalovic, J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136, 2015\u20132031 (2009).","journal-title":"Gastroenterology"},{"key":"103_CR188","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink, B. A. et al. The microbiome, cancer, and cancer therapy. Nat. Med. 25, 377\u2013388 (2019).","journal-title":"Nat. Med."},{"key":"103_CR189","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/microorganisms8020166","volume":"8","author":"A Feehan","year":"2020","unstructured":"Feehan, A. & Garcia-Diaz, J. Bacterial, gut microbiome-modifying therapies to defend against multidrug resistant organisms. Microorganisms 8, 166 (2020).","journal-title":"Microorganisms"},{"key":"103_CR190","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1515\/revneuro-2019-0005","volume":"30","author":"AO Sasmita","year":"2019","unstructured":"Sasmita, A. O. Modification of the gut microbiome to combat neurodegeneration. Rev. Neurosci. 30, 795\u2013805 (2019).","journal-title":"Rev. Neurosci."},{"key":"103_CR191","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41587-019-0233-9","volume":"37","author":"T Wilmanski","year":"2019","unstructured":"Wilmanski, T. et al. Blood metabolome predicts gut microbiome \u03b1-diversity in humans. Nat. Biotechnol. 37, 1217\u20131228 (2019).","journal-title":"Nat. Biotechnol."},{"key":"103_CR192","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","volume":"27","author":"F Asnicar","year":"2021","unstructured":"Asnicar, F. et al. Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals. Nat. Med. 27, 321\u2013332 (2021).","journal-title":"Nat. Med."},{"key":"103_CR193","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1038\/s41588-018-0224-7","volume":"50","author":"DV Zhernakova","year":"2018","unstructured":"Zhernakova, D. V. et al. Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome. Nat. Genet. 50, 1524\u20131532 (2018).","journal-title":"Nat. Genet."},{"key":"103_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69560-8","volume":"14","author":"SS Matin","year":"2024","unstructured":"Matin, S. S. et al. The impact of synbiotic on serum sCD163\/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial. Sci. Rep. 14, 19120 (2024).","journal-title":"Sci. Rep."},{"key":"103_CR195","first-page":"125","volume":"164","author":"T Vlaykova","year":"2013","unstructured":"Vlaykova, T. et al. Effects of acute Staphylococcus aureus infection on paraoxonase activity, thiol concentrations and ferric reducing ability of plasma in rabbits. Rev. M\u00e9d. V\u00e9t\u00e9. 164, 125\u2013131 (2013).","journal-title":"Rev. M\u00e9d. V\u00e9t\u00e9."},{"key":"103_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep28778","volume":"6","author":"S Tao","year":"2016","unstructured":"Tao, S. et al. Paraoxonase 2 modulates a proapoptotic function in LS174T cells in response to quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone. Sci. Rep. 6, 1\u201312 (2016).","journal-title":"Sci. Rep."},{"key":"103_CR197","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.lfs.2018.03.049","volume":"201","author":"S Tao","year":"2018","unstructured":"Tao, S. et al. N-(3-oxododecanoyl)-l-homoserine lactone modulates mitochondrial function and suppresses proliferation in intestinal goblet cells. Life Sci. 201, 81\u201388 (2018).","journal-title":"Life Sci."},{"key":"103_CR198","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1128\/IAI.01606-07","volume":"76","author":"JF Teiber","year":"2008","unstructured":"Teiber, J. F. et al. Dominant role of paraoxonases in inactivation of the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone. Infect. Immun. 76, 2512\u20132519 (2008).","journal-title":"Infect. Immun."},{"key":"103_CR199","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1042\/BJ20091414","volume":"426","author":"S Horke","year":"2010","unstructured":"Horke, S. et al. Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorum-sensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin. Biochem. J. 426, 73\u201383 (2010).","journal-title":"Biochem. J."},{"key":"103_CR200","doi-asserted-by":"crossref","unstructured":"Griffin, P.E. et al. Expression of PPAR\u03b3 and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis. PLoS One 7, e42241 (2012).","DOI":"10.1371\/journal.pone.0042241"},{"key":"103_CR201","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WW Tang","year":"2014","unstructured":"Tang, W. W. et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908\u20131914 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"103_CR202","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"103_CR203","doi-asserted-by":"publisher","first-page":"eabh2169","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson, M. et al. A single\u2013cell type transcriptomics map of human tissues. Sci. Adv. 7, eabh2169 (2021).","journal-title":"Sci. Adv."}],"container-title":["npj Metabolic Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00103-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00103-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00103-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:03:12Z","timestamp":1784059392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00103-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":203,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1038\/s44324-026-00103-7","relation":{},"ISSN":["2948-2828"],"issn-type":[{"value":"2948-2828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"26"}}